Addex Therapeutics Ltd. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -10.48M-8.97M13.60M
Depreciation and Depletion 0.02M0.00M0.34M0.40M0.38M0.34M0.34M0.30M
Share-based Compensation 0.81M2.35M1.70M1.25M1.29M3.86M2.00M0.57M
Gains from Investment Securities -0.01M-138.980.37M0.37M0.05M
Cash from Operations -2.17M1.79M-9.55M-12.99M-16.09M-17.23M-8.90M-6.11M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.02M0.00M0.34M0.40M0.38M0.34M0.34M0.30M
Change in Working Capital
Change in Receivables -0.08M-0.08M0.16M0.05M-0.11M-0.26M0.34M0.11M
Change in Account Payables -0.22M1.11M1.98M-1.69M0.97M-0.45M-0.68M-1.30M
Other Working Capital Changes -0.14M-0.04M-0.52M0.24M-0.68M0.89M0.06M-0.19M
Investing Activities
Capital Expenditures 708.120.01M0.03M0.06M0.03M609.050.01M0.00M
Sales of Property, Plant and Equipment 5.82M
Cash from Investing Activities -708.12-0.06M-0.04M-0.06M-0.03M0.00M-0.01M5.28M
Financing Activities
Cash from Financing Activities 3.41M38.23M-0.47M0.05M17.95M3.25M5.86M0.12M
Additional items
Exchange Rate Effect -0.05M0.01M-0.15M-0.69M0.13M-0.21M-0.40M0.11M
Change in Cash 1.23M39.97M-10.06M-13.00M1.82M-13.98M-3.04M-0.71M
Beginning Cash Balance -1.23M-39.97M10.06M13.00M-1.82M21.27M7.35M4.51M
Free Cash Flow -2.17M1.78M-9.57M-13.05M-16.13M-17.23M-8.91M-6.11M
Net Cash Flow 1.23M39.97M-10.06M-13.00M1.82M-13.98M-3.04M-0.71M